Reducing Dietary Sodium to 1000 mg per Day Reduces Neurovascular Transduction Without Stimulating Sympathetic Outflow
Open accessAbstract
The American Heart Association recommends no more than 1500 mg of sodium/day as ideal. Some cohort studies suggest low-sodium intake is associated with increased cardiovascular mortality. Extremely low-sodium diets (≤500 mg/d) elicit activation of the renin-angiotensin-aldosterone system and stimulate sympathetic outflow. The effects of an American Heart Association–recommended diet on sympathetic regulation of the vasculature are unclear. Therefore, we assessed whether a 1000 mg/d diet alters sympathetic outflow and sympathetic vascular transduction compared with the more commonly recommended 2300 mg/d. We hypothesized that sodium reduction from 2300 to 1000 mg/d would not affect resting sympathetic outflow but would reduce sympathetic transduction in healthy young adults. Seventeen participants (age: 26±2 years, 9F/8M) completed 10-day 2300 and 1000 mg/d sodium diets in this randomized controlled feeding study (crossover). We measured resting renin activity, angiotensin II, aldosterone, blood pressure, muscle sympathetic nerve activity, and norepinephrine. We quantified beat-by-beat changes in mean arterial pressure and leg vascular conductance (femoral artery ultrasound) following spontaneous sympathetic bursts to assess sympathetic vascular transduction. Reducing sodium to 1000 mg/d increased renin activity, angiotensin II, and aldosterone ( P <0.01 for all) but did not alter mean arterial pressure (78±2 versus 77±2 mm Hg, P =0.56), muscle sympathetic nerve activity (13.9±1.3 versus 13.9±0.8 bursts/min, P =0.98), or plasma/urine norepinephrine. Sympathetic vascular transduction decreased ( P <0.01). These data suggest that reducing sodium from 2300 to 1000 mg/d stimulates the renin-angiotensin-aldosterone system, does not increase resting basal sympathetic outflow, and reduces sympathetic vascular transduction in normotensive adults.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
31 of 40 cited sources checked · 12 supported · 0 flagged · accuracy not yet measured
- Premisecitation
In normotensive people at elevated risk of future hypertension, each MSNA burst has been reported to cause larger drops in vascular conductance and rises in blood pressure.
“Greater declines in vascular conductance and increases in BP with each burst of MSNA (i.e., neurovascular transduction) have recently been reported in normotensive individuals who are at heightened risk for future development of hypertension,20”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [20] source
- Premisecitation
Few people voluntarily consume a diet as low as 500 mg sodium per day.
“it is rare for anyone to voluntarily follow a diet that low in sodium,19”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [19] source
The Discussion (page not specified) reports mean 24-hour sodium excretion of about 3,526 mg, well above the 500 mg/day level in the claim. That supports the point that typical intake is much higher, but the paper does not establish how rarely individuals voluntarily follow a 500 mg/day diet. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Premisecitation
Sodium intake and RAAS activation are strongly inversely related.
“Due to the robust inverse relation between sodium intake and RAAS activation,7, 17, 18”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [7] source
The ‘Effect on hormones and lipids’ section reports that modest salt reduction produced a small increase in plasma renin activity and aldosterone, supporting an inverse direction of effect. It does not establish a robust inverse relation across sodium intakes; the hormone measurements came from trials lasting only four to six weeks, and the authors say the effects might attenuate over time. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [17] source
- cites [18] source
- Premisecitation
The RAAS values on the 1000 mg/day diet were within normal physiological ranges previously reported.
“the values we present here are within normal physiological values previously reported in the literature 34”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [34] source
- Premisecitation
Long-term sodium reduction lowers blood pressure at the population level.
“there is a large body of literature suggesting that long-term reductions in sodium elicit reductions in BP at the population level.2, 3”
Quote in the paperNot a substantial claim1 of 2 sources checked - Findingown data
Urinary sodium excretion fell by 49.7±9.3% on the 1000 mg/day diet compared with the 2300 mg/day diet.
“we report a 49.7±9.3% decline in urinary sodium excretion when participants were on the 1000mg sodium diet compared to the 2300mg to the diet.”
Quote in the paperSubstantial claim - Findingown data
The 1000 mg/day sodium diet did not change mean arterial pressure compared with the 2300 mg/day diet.
“did not alter mean arterial pressure (78±2 vs. 77±2mmHg, p=0.56)”
Quote in the paperSubstantial claim - Findingown data
The average daily sodium content was 2305±6 mg for the 2300 mg/day diet and 128±13 mg for the 1000 mg/day diet.
“Average daily sodium content in the 2300 and 1000mg/d diets were 2305±6 and 128±13, respectively.”
Quote in the paperSubstantial claim - Findingown data
Across both diets, the peak change in mean arterial pressure after a burst correlated with mean arterial pressure variability (r=0.56, p<0.02).
“Irrespective of dietary condition, the peak change in MAP was correlated with MAP variability (Pearson’s r=0.56, p<0.02).”
Quote in the paperNot a substantial claim - Findingown data
Heart rate variability measures did not differ between the two diets.
“Measures of HRV were not different between diets.”
Quote in the paperSubstantial claim - Findingown data
Changes in aldosterone correlated with changes in transduction measured by leg vascular conductance (r=-0.92, p<0.01).
“Changes in aldosterone were significantly related to the change in transduction measured via LVC (n=8, Pearson’s r=−0.92, p<0.01).”
Quote in the paperNot a substantial claim - Findingown data
Changes in plasma renin activity correlated with changes in transduction measured by leg vascular conductance (r=-0.95, p<0.01).
“Changes in PRA were significantly related to the change in transduction measured via LVC (n=8, Pearson’s r=−0.95, p<0.01).”
Quote in the paperNot a substantial claim - Findingown data
Blood pressure variability did not differ between the 2300 and 1000 mg/day diets (MAP ARV 1.58±0.16 vs 1.31±0.08, p=0.18).
“there was no difference between the diets regarding BP variability (2300mg/d sodium diet vs 1000mg/d sodium diet MAP ARV = 1.58±0.16 vs. 1.31±0.08, p=0.18).”
Quote in the paperSubstantial claim - Findingown data
The 1000 mg/day sodium diet did not change muscle sympathetic nerve activity compared with the 2300 mg/day diet.
“muscle sympathetic nerve activity (13.9±1.3 vs. 13.9±0.8bursts/min, p=0.98)”
Quote in the paperSubstantial claim - Findingown data
The 1000 mg/day sodium diet reduced sympathetic vascular transduction compared with the 2300 mg/day diet.
“Sympathetic vascular transduction decreased (p<0.01).”
- Also stated in: § Results · plain
“Neurovascular transduction was lower on the 1000mg/d diet compared to the 2300mg/d sodium diet”
Quote in the paperSubstantial claim - Also stated in: § Results · plain
- Study design and conductown data
The large difference in 24-hour urinary sodium excretion supports the dietary intervention used to change sodium intake.
“The large difference in 24-hour urinary sodium excretion demonstrated here support the dietary intervention utilized to alter sodium intake.”
Quote in the paperSubstantial claim - Interpretationown data
The study's data support a potentially beneficial effect of sodium reduction on sympathetic transduction.
“our data here support a potentially beneficial effect of sodium reduction on sympathetic transduction”
Quote in the paperSubstantial claim - Premisereasoning
The AHA's optimal sodium recommendation is moderately above the sodium level used in this study.
“the AHA recommendation for optimal sodium intake, which is moderately above the level of sodium used here”
Quote in the paperSubstantial claim - Interpretationreasoning
The reduction in neurovascular transduction with sodium reduction may be a previously unrecognized benefit for future hypertension risk.
“the decline in neurovascular transduction with sodium reduction in the present study may be a previously unappreciated benefit of reducing sodium from a future hypertension risk perspective.”
Quote in the paperNot a substantial claim - Interpretationreasoning
A decrease in dietary sodium causes compensatory RAAS activation to maintain electrolyte balance.
“Hence, a reduction in dietary sodium leads to compensatory RAAS activation to maintain electrolyte homeostasis.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Dietary salt-induced changes in sympathetic transduction may be clinically important.
“Taken together, these findings suggest that dietary salt-induced alterations in sympathetic transduction may have important clinical relevance”
Quote in the paperNot a substantial claim - Interpretationreasoning
The AHA's optimal sodium recommendation, which is moderately above the level tested here, is unlikely to raise baseline sympathetic outflow in healthy adults.
“Thus, the AHA recommendation for optimal sodium intake, which is moderately above the level of sodium used here, are not likely to cause an increase in baseline sympathetic outflow in healthy adults.”
Quote in the paperSubstantial claim - Interpretationown data
People whose RAAS increased more during sodium restriction had a smaller reduction in transduction.
“These data suggest that individuals that experienced greater increases in the RAAS during sodium restriction had less of a diminshment in transduction.”
Quote in the paperSubstantial claim
- May combine two claims. 16
- Classified as probably not a substantial claim. 20
May combine two claims.
PremisecitationDiets with sodium at or below 500 mg per day activate the renin-angiotensin-aldosterone system and raise sympathetic outflow.
“Extremely low sodium diets (≤500mg/d) elicit activation of the renin-angiotensin-aldosterone system and stimulate sympathetic outflow.”
- Also stated in: § Introduction · boosted
“Experimental studies using extremely low sodium diets (≤500mg/d) increase muscle sympathetic nerve activity (MSNA)14–16 and elicit a robust activation of the renin angiotensin aldosterone system (RAAS).7, 17, 18”
Quote in the paperSubstantial claim3 of 6 sources checked- cites [14] source
- cites [15] source
- cites [16] source
- cites [7] source
The ‘Effect on hormones and lipids’ section says salt reduction stimulates the renin-angiotensin-aldosterone and sympathetic systems, particularly after sudden, large reductions. It does not establish a threshold of ≤500 mg of sodium per day; its own meta-analysis concerns longer-term modest salt reduction and reports only small physiological increases. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [17] source
The Methods describe a low-sodium diet of 20 mmol/day (about 460 mg/day), and the Results report higher plasma renin activity and serum aldosterone on that diet than on the high-sodium diet. This supports the renin–aldosterone portion for the studied adults, but the paper does not report increased sympathetic outflow or establish the claim for all diets at or below 500 mg/day. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [18] source
The Methods describe a low-sodium diet of 20 mmol/day (about 460 mg/day), and the Results show higher renin activity, angiotensin II, and aldosterone on that diet than on the high-sodium diet. The paper does not report sympathetic outflow, so it does not support that part of the claim. Page numbers are unavailable in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Also stated in: § Introduction · boosted
Classified as probably not a substantial claim.
PremisecitationThe American Heart Association's ideal sodium intake recommendation is no more than 1500 mg per day.
“The American Heart Association recommends no more than 1500mg of sodium/day as ideal.”
- Also stated in: § Introduction · plain
“the American Heart Association (AHA) recommends no more than 1500mg/d of sodium as ideal for CV health.3–7”
Quote in the paperSubstantial claim4 of 5 sources checked- cites [3] source
- cites [4] source
The Introduction discusses international salt-intake recommendations, and the Implications section identifies a WHO target of 5 g of salt per day. Searches for the American Heart Association and a 1500 mg/day sodium limit found no passage in our copy stating the claimed recommendation; the WHO target does not establish what the AHA recommends. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [5] source
- cites [6] source
The Introduction discusses an Institute of Medicine assessment of sodium intake below 2,300 mg/day, and the Discussion mentions an Institute of Medicine recommendation for gradual sodium reduction. Neither passage states the American Heart Association’s ideal intake recommendation. Searches for the American Heart Association and a 1,500 mg/day limit found no passage in our copy establishing the claim. (LLM, conf=0.72)
Experimental — accuracy not yet measured - cites [7] source
The Dose-response to salt reduction section reports a US recommendation of 1.5 g (1500 mg) sodium per day, but only for about half the population; it gives a limit of less than 2.3 g/day for most adults. The passage does not identify the American Heart Association as the source or describe 1500 mg/day as its ideal recommendation. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Also stated in: § Introduction · plain
Classified as probably not a substantial claim.
Study design and conductcitationThe spike-triggered averaging methods have been shown to reliably quantify changes in blood pressure and blood flow caused by MSNA bursts.
“These methods have been shown to reliably quantify changes in BP and blood flow induced by bursts of MSNA.26, 27”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [26] source
The Methods and Results (pages unavailable) show that spike-triggered averaging quantified changes in mean arterial pressure and leg vascular conductance following MSNA bursts, with no systematic changes in the white-noise control. The paper measured femoral blood flow to calculate conductance, but it does not report burst-triggered changes in blood flow itself or directly test the method’s reliability. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [27] source
The Methods describe spike-triggered averaging of mean arterial pressure and forearm vascular conductance after MSNA bursts. The Results report changes in both, while the Discussion says a white-noise control supports the method’s specificity. The paper reports burst-triggered conductance, however, rather than directly quantifying burst-triggered blood flow. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe 2013 AHA/American College of Cardiology guidelines concluded that lowering habitual sodium to 2400 mg/day reduces blood pressure, and lowering further to 1500 mg/day reduces it more.
“In the 2013 joint AHA/American College of Cardiology guidelines on lifestyle management to CV risk, it was concluded that reducing habitual sodium to 2,400mg/d results in BP reduction, and a further sodium reduction to 1500mg/d results in an even greater reduction in BP.41”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [41] source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRacial differences in neurovascular transduction appear to contribute to exaggerated blood pressure variability in African American males, who are at higher risk of future hypertension.
“Importantly the racial differences in neurovascular transduction appear to contribute to exaggerated BP variability in African American males, a group at heightened risk for future incidence of hypertension.20”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [20] source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSympathetic vascular transduction is likely affected by circulating vasoconstrictors and vasodilators such as endothelin-1 and nitric oxide.
“In addition, sympathetic vascular transduction is likely influenced by circulating vasoconstrictors and vasodilators such as endothlin-138 and nitric oxide.39”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [38] source
The Perspectives (p. 9) report that endothelin-A signaling constrains blood flow during exercise in older adults, supporting endothelin-1’s role in vascular tone. The paper does not establish that endothelin-1 alters sympathetic vascular transduction specifically. Nitric oxide has a separate citation in the citing sentence and is not assessed here. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [39] source
The Results and Discussion show that nitric oxide contributes to vasodilation in the superficial femoral artery after a brief ischemic stimulus. The paper does not examine whether nitric oxide influences sympathetic vascular transduction, which is the specific relationship attributed to it here. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHigh sodium intake does not increase urine volume.
“in accordance with recent findings indicating that high sodium intake does not increase urine volume.32”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [32] source
The Figure 1 results report that a 6-g/day increase in salt intake did not significantly increase urine volume. The unqualified claim is stronger than that finding: the Discussion (p. 1938) notes divergent results in other studies, and the paper reports some diuresis with increased urinary salt excretion. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe authors previously found even higher RAAS levels with a 500 mg/day sodium diet without short-term adverse effects.
“we have previously shown even greater RAAS levels using a 500 mg/d sodium diets with no short-term adverse effects.18”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [18] source
The Methods (page unavailable) describe a seven-day low-sodium diet of 20 mmol/day, approximately 460 mg/day. The Results (page unavailable) report higher renin activity, angiotensin II, and aldosterone on that diet than on the high-sodium diet, with no difference in measured blood pressure. The paper does not establish the broader claim that the low-sodium diet had no short-term adverse effects. (LLM, conf=0.83)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNeurovascular transduction is mediated by α-adrenergic receptors.
“This work has established that neurovascular transduction is mediated by α-adrenergic receptors,27”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [27] source
The Abstract reports that α-adrenergic blockade eliminated the forearm vasoconstriction following sympathetic bursts in young men at rest. But the Discussion says the initial increase in forearm vascular conductance was unchanged by blockade. The source therefore supports α-adrenergic mediation of the vasoconstrictor component, not neurovascular transduction without qualification. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationReduced sodium diets improve endothelial function and nitric oxide bioavailability.
“We have previously demonstrated that reduced sodium diets result in improved endothelial function and nitric oxide bioavailability.13, 17, 21, 40”
Quote in the paperNot a substantial claim4 of 4 sources checked- cites [13] source
The ARTERIES section (page unavailable) reports that sodium restriction improved endothelial function in adults with elevated blood pressure. It also says high sodium likely reduces nitric oxide bioavailability, but does not establish that a reduced-sodium diet improves nitric oxide bioavailability. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [17] source
The Results (page not provided) report higher brachial artery flow-mediated dilation during the low-sodium diet than during the high-sodium diet, supporting improved endothelial function. The Discussion (page not provided) explicitly says the study did not assess altered nitric oxide bioavailability, so it does not establish that the reduced-sodium diet improved it. (LLM, conf=0.91)
Experimental — accuracy not yet measured - cites [21] source
The Results (Vascular Function; page unavailable) report higher flow-mediated dilation on the low-sodium diet than on the high-sodium diet, supporting the endothelial-function part of the claim. The Discussion (page unavailable) says the mechanism is unknown and discusses nitric oxide only as a possible explanation; it does not report improved nitric oxide bioavailability. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [40] source
The Microvascular function results report better cutaneous vasodilation on the low-sodium than the high-sodium diet in normotensive adults with salt-resistant blood pressure. However, the difference in nitric oxide’s contribution between diets did not reach statistical significance (P = 0.075), and nitric oxide bioavailability was not directly measured. The claim therefore overstates that part of the finding and generalizes beyond the microvascular response studied. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
Findingnone givenSerum sodium and urinary sodium excretion were lower on the 1000 mg/day diet than on the 2300 mg/day diet.
“Serum sodium and urinary sodium excretion were lower on the 1000mg/d diet compared to the 2300mg/d diet (Table 2).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe 1000 mg/day sodium diet did not change plasma or urinary norepinephrine compared with the 2300 mg/day diet.
“or plasma/urine norepinephrine.”
- Also stated in: § Results · plain
“plasma NE was not different on the 1000mg/d sodium diet compared to the 2300mg/d sodium diet (Figure 2E). Urinary NE excretion was also not different on the 1000mg/day sodium diet compared to the 2300mg/d sodium diet (30.6±3.3 vs. 23.5±3.1ng/min, p>0.10).”
Quote in the paperSubstantial claim- Also stated in: § Results · plain
May combine two claims.
Findingown dataThe 1000 mg/day sodium diet raised plasma renin activity, angiotensin II, and aldosterone relative to the 2300 mg/day diet.
“Reducing sodium to 1000 mg/d increased renin activity, angiotensin II, and aldosterone (p<0.01 for all)”
- Also stated in: § Results · plain
“PRA (Figure 1A), circulating Aldo (Figure 1B), and Ang-II (Figure 1C) were elevated on the 1000mg/d diet compared to the 2300mg/d sodium diet.”
Quote in the paperSubstantial claim- Also stated in: § Results · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataUrine volume was similar between the two diets.
“Urine volume was also similar between diets”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn a subset, changes in angiotensin II correlated with changes in transduction measured by MAP (r=0.84, p=0.01) and by leg vascular conductance (r=-0.80, p=0.03).
“Changes in Ang II were significantly related to the change in transduction measured via MAP (n=8, Pearson’s r=0.84, p=0.01) and LVC (n=7, Pearson’s r=−0.80, p=0.03).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationRenal sodium excretion and RAAS hormones are inversely related, with higher RAAS activity causing greater sodium reabsorption.
“The RAAS hormones are inversely related to sodium excretion by the kidneys, whereby elevated RAAS activity results in greater sodium reabsorption.33”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductown dataThe two diets were isocaloric and matched for potassium at 2500 mg/day.
“The diets were 10 days each, isocaloric, matched for potassium (2500mg/d), and given in a randomized order separated by a ≥four-week washout.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe study did not control for menstrual status in female participants.
“we did not control for menstrual status in female participants.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenSympathetic neurograms were visually inspected by a blinded lab member trained in MSNA analysis.
“Sympathetic neurograms were analyzed using custom LabView software and visually inspected by a blinded lab member (MCB), trained in MSNA data analysis and processing.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThe 1000 mg/day sodium diet is below the AHA recommendation of no more than 1500 mg/day for optimal cardiovascular health.
“It is also worth noting that the 1000mg/d of sodium here is below the AHA recommendation of no more than 1500mg of sodium per day for optimal CV health.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe RAAS may enhance sympathetically mediated vasoconstriction, so people with higher RAAS have greater vasoconstriction for a given sympathetic outflow.
“These relations indicate that the RAAS may potentiate sympathetically-mediated vasoconstriction, such that individuals with elevated RAAS have greater vasoconstriction for a given level of sympathetic outflow.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningBecause sodium is the main solute in extracellular fluid, sodium reduction is expected to raise RAAS to preserve extracellular fluid volume.
“Sodium is the major solute in extracellular fluids, hence it is expected that a reduction in sodium would lead to a compensatory increase in the RAAS to maintain extracellular fluid volume.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataInvestigators did not know which diet each participant was assigned to.
“Investigators were blinded to participant’s diet assignment.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataBecause video recording was inadequate in three participants, leg vascular conductance results came from eight of the 11 participants with paired nerve recordings.
“Due to an inadequate video recording in three participants, LVC is reported in eight of the 11 participants who had paired nerve recordings.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningBecause the sodium reduction was modest and the participants were young and healthy, these findings apply more to the general population than earlier very-low-sodium studies.
“Given the more modest sodium reduction employed in the present study, along with the fact that the population was younger and healthy, the present findings are more applicable to the general population.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataParticipants ate 10-day 2300 and 1000 mg/day sodium diets in randomized order with at least a four-week washout between them.
“The diets were 10 days each, isocaloric, matched for potassium (2500mg/d), and given in a randomized order separated by a ≥four-week washout.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe study protocol was approved by the University of Delaware Institutional Review Board and conformed to the Declaration of Helsinki.
“the study protocol and procedures were approved by the Institutional Review Board of the University of Delaware and conform to the provisions of the Declaration of Helsinki.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataIn normotensive adults, lowering sodium from 2300 to 1000 mg/day stimulates the RAAS, does not raise resting sympathetic outflow, and reduces sympathetic vascular transduction.
“These data suggest that reducing sodium from 2300 to 1000mg/day stimulates the renin- angiotensin-aldosterone system, does not increase resting basal sympathetic outflow, and reduces sympathetic vascular transduction in normotensive adults.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataThe study used a randomized, crossover, controlled feeding design.
“We performed a randomized, crossover, controlled feeding study”
- Also stated in: § Abstract · plain
“randomized controlled feeding study (crossover)”
Quote in the paperSubstantial claim- Also stated in: § Abstract · plain
May combine two claims.
InterpretationreasoningThe modest RAAS increase from this sodium restriction may help maintain blood pressure, since the observed reduction in sympathetic transduction would otherwise be expected to lower MAP.
“It may also be that the modest increase in RAAS observed with this level of sodium restriction act to support BP, as we observed attenuations in sympathetic transduction that would otherwise be expected to lower MAP.”
Quote in the paperSubstantial claim
The authors state this as an assumption.
The effect of an AHA-recommended diet on sympathetic control of the vasculature is unclear.
“The effects of an American Heart Association-recommended diet on sympathetic regulation of the vasculature are unclear”
The authors state this as an assumption.
The effect of an AHA-like low-sodium diet on MSNA and RAAS has not been established in healthy normotensive people.
“The effects of a low sodium diet—like that recommended by the AHA—on MSNA and the RAAS have not been determined in healthy normotensive humans.”
The authors state this as an assumption.
Data on how dietary sodium affects neurovascular transduction are scarce.
“There is also a paucity of data on the effects of dietary sodium on neurovascular transduction”
The paper relies on this without support.
Endothelial-derived vasodilators may reduce neurovascular transduction.
“because endothelial-derived vasodilator compounds may blunt neurovascular transduction”
The authors state this as an assumption.
This study is the first to examine or document dietary sodium-induced changes in neurovascular transduction.
“To our knowledge, this is the first study to examine dietary sodium-induced alterations in neurovascular transduction.”
“to our knowledge, these data are the first to document a dietary sodium-induced alteration in sympathetic transduction.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Reported sodium content conflicts with the stated low-sodium diet
MinorThe Results give the 1000 mg/day diet an average sodium content of 128±13 mg/day, far below the 1000 mg/day specified in Methods. This discrepancy affects the intervention underlying the paper's conclusions.
“Average daily sodium content in the 2300 and 1000mg/d diets were 2305±6 and 128±13, respectively.”
“The lower sodium diet consisted of 1000mg/d (2.6g NaCl/d), and the moderate/recommended sodium diet consisted of 2300mg/d (6.0g NaCl/d).”
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591 · see citing works
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391 · see citing works
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347 · see citing works
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Miller, N. H., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437740.48606.d1 · Cited by 2,261 · see citing works
Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies
Strazzullo, P., D'Elia, L., Kandala, N.-B., & Cappuccio, F. P. (2009) · BMJ · doi:10.1136/bmj.b4567 · Cited by 1,580 · see citing works
He, F. J., Li, J., & MacGregor, G. A. (2013) · BMJ · doi:10.1136/bmj.f1325 · Cited by 1,358 · see citing works
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.003 · Cited by 1,160 · see citing works
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Himmelfarb, C. D., DePalma, S. M., Gidding, S. S., Jamerson, K., Jones, D. W., et al. (2018) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2018.06.010 · Cited by 947 · see citing works
Anderson, E. A., Sinkey, C. A., Lawton, W. J., & Mark, A. L. (1989) · Hypertension · doi:10.1161/01.hyp.14.2.177 · Cited by 632 · see citing works
Stolarz-Skrzypek, K. (2011) · JAMA · doi:10.1001/jama.2011.574 · Cited by 569 · see citing works
Whelton, P. K., Appel, L. J., Sacco, R. L., Anderson, C. A. M., Antman, E. M., Campbell, N., Dunbar, S. B., Frohlich, E. D., Hall, J. E., Jessup, M., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318279acbf · Cited by 463 · see citing works
Graudal, N., Jürgens, G., Baslund, B., & Alderman, M. H. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu028 · Cited by 407 · see citing works
Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials
He, F. J., & MacGregor, G. A. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61174-4 · Cited by 391 · see citing works
Farquhar, W. B., Edwards, D. G., Jurkovitz, C. T., & Weintraub, W. S. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.12.039 · Cited by 348 · see citing works
Self-citationMente, A., O'Donnell, M., Rangarajan, S., McQueen, M., Dagenais, G., Wielgosz, A., Lear, S., Ah, S. T. L., Wei, L., Diaz, R., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31376-x · Cited by 332 · see citing works
Cobb, L. K., Anderson, C. A. M., Elliott, P., Hu, F. B., Liu, K., Neaton, J. D., Whelton, P. K., Woodward, M., & Appel, L. J. (2014) · Circulation · doi:10.1161/cir.0000000000000015 · Cited by 300 · see citing works
Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention
Cook, N. R., Appel, L. J., & Whelton, P. K. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.07.745 · Cited by 228 · see citing works
Mena, L. J., Félix, V. G., Melgarejo, J. D., & Maestre, G. E. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006895 · Cited by 223 · see citing works
Flow‐mediated dilatation in the superficial femoral artery is nitric oxide mediated in humans
Kooijman, M., Thijssen, D. H. J., De Groot, P. C. E., Bleeker, M. W. P., Van Kuppevelt, H. J. M., Green, D. J., Rongen, G. A., Smits, P., & Hopman, M. T. E. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.145722 · Cited by 207 · see citing works
Central sympathetic overactivity: Maladies and mechanisms
Fisher, J. P., Young, C. N., & Fadel, P. J. (2009) · Autonomic Neuroscience · doi:10.1016/j.autneu.2009.02.003 · Cited by 202 · see citing works
Agreement Between 24-Hour Salt Ingestion and Sodium Excretion in a Controlled Environment
Lerchl, K., Rakova, N., Dahlmann, A., Rauh, M., Goller, U., Basner, M., Dinges, D. F., Beck, L., Agureev, A., Larina, I., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05851 · Cited by 198 · see citing works
Trends in 24-h urinary sodium excretion in the United States, 1957–2003: a systematic review
Bernstein, A. M., & Willett, W. C. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29367 · Cited by 166 · see citing works
Hart, E. C., Head, G. A., Carter, J. R., Wallin, B. G., May, C. N., Hamza, S. M., Hall, J. E., Charkoudian, N., & Osborn, J. W. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00703.2016 · Cited by 166 · see citing works
Increased salt consumption induces body water conservation and decreases fluid intake
Rakova, N., Kitada, K., Lerchl, K., Dahlmann, A., Birukov, A., Daub, S., Kopp, C., Pedchenko, T., Zhang, Y., Beck, L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88530 · Cited by 157 · see citing works
Fairfax, S. T., Padilla, J., Vianna, L. C., Davis, M. J., & Fadel, P. J. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00842.2012 · Cited by 144 · see citing works
High dietary sodium intake impairs endothelium-dependent dilation in healthy salt-resistant humans
DuPont, J. J., Greaney, J. L., Wenner, M. M., Lennon-Edwards, S. L., Sanders, P. W., Farquhar, W. B., & Edwards, D. G. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835c6ca8 · Cited by 135 · see citing works
Self-citationGunnar Wallin, B., & Nerhed, C. (1982) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(82)90002-9 · Cited by 119 · see citing works
Greaney, J. L., DuPont, J. J., Lennon‐Edwards, S. L., Sanders, P. W., Edwards, D. G., & Farquhar, W. B. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.236992 · Cited by 119 · see citing works
Self-citationFairfax, S. T., Holwerda, S. W., Credeur, D. P., Zuidema, M. Y., Medley, J. H., Dyke II, P. C., Wray, D. W., Davis, M. J., & Fadel, P. J. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.250894 · Cited by 108 · see citing works
Charkoudian, N., & Wallin, B. G. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130038 · Cited by 107 · see citing works
Vranish, J. R., Holwerda, S. W., Young, B. E., Credeur, D. P., Patik, J. C., Barbosa, T. C., Keller, D. M., & Fadel, P. J. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10229 · Cited by 98 · see citing works
Evidence for increased renal norepinephrine overflow during sodium restriction in humans.
Friberg, P., Meredith, I. T., Jennings, G., Lambert, G. W., Fazio, V., & Esler, M. D. (1990) · Hypertension · doi:10.1161/01.hyp.16.2.121 · Cited by 91 · see citing works
(1990) · PubMed · Cited by 64 · see citing works
Rifkin, D. E., Khaki, A. R., Jenny, N. S., McClelland, R. L., Budoff, M. J., Watson, K. E., Ix, J. H., & Allison, M. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpt276 · Cited by 62 · see citing works
Matthews, E. L., Brian, M. S., Ramick, M. G., Lennon-Edwards, S., Edwards, D. G., & Farquhar, W. B. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00023.2015 · Cited by 60 · see citing works
Self-citationBaroreflex Impairment by Low Sodium Diet in Mild or Moderate Essential Hypertension
Grassi, G., Cattaneo, B. M., Seravalle, G., Lanfranchi, A., Bolla, G., & Mancia, G. (1997) · Hypertension · doi:10.1161/01.hyp.29.3.802 · Cited by 60 · see citing works
Sodium intake among adults - United States, 2005-2006.
(2010) · PubMed · Cited by 56 · see citing works
Lennon-Edwards, S., Ramick, M. G., Matthews, E. L., Brian, M. S., Farquhar, W. B., & Edwards, D. G. (2014) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.05.004 · Cited by 49 · see citing works
Self-citationEndothelin-A -Mediated Vasoconstriction During Exercise With Advancing Age
Barrett-O’Keefe, Z., Ives, S. J., Trinity, J. D., Morgan, G., Rossman, M. J., Donato, A. J., Runnels, S., Morgan, D. E., Gmelch, B. S., Bledsoe, A. D., et al. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu065 · Cited by 43 · see citing works
Goessler, K., Polito, M., & Cornelissen, V. (2016) · Hypertension Research · doi:10.1038/hr.2015.100 · Cited by 43 · see citing works
Walker, W. G., Moore, M. A., Horvath, J. S., & Whelton, P. K. (1976) · Circulation Research · doi:10.1161/01.res.38.6.477 · Cited by 28 · see citing works
Xia, Y., Wu, D., Gao, Z., Liu, X., Chen, Q., Ren, L., & Wu, W. (2017) · Medicine · doi:10.1097/md.0000000000006000 · Cited by 28 · see citing works
Abrahão, S. B., Tinucci, T., Santello, J. L., & Mion, D. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001492 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Graudal, N. A., Hubeck‐Graudal, T., & Jűrgens, G. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004022.pub5 · Cited by 130 · see citing works
The Influence of Dietary Salt Beyond Blood Pressure
Robinson, A. T., Edwards, D. G., & Farquhar, W. B. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0948-5 · Cited by 113 · see citing works
Self-citationSympathetic transduction in humans: recent advances and methodological considerations
Young, B. E., Greaney, J. L., Keller, D. M., & Fadel, P. J. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00926.2020 · Cited by 56 · see citing works
Inflammation and oxidative stress in salt sensitive hypertension; The role of the NLRP3 inflammasome
Ertuğlu, L. A., Mutchler, A. P., Yu, J. D., & Kirabo, A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1096296 · Cited by 53 · see citing works
Watso, J. C., Fancher, I. S., Gomez, D. H., Hutchison, Z. J., Gutiérrez, O. M., & Robinson, A. T. (2023) · Obesity Reviews · doi:10.1111/obr.13589 · Cited by 38 · see citing works
Self-citationXiao, H., Yan, Y., Gu, Y., & Zhang, Y. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110822 · Cited by 28 · see citing works
O'Brien, M. W., Ramsay, D. J., Johnston, W., & Kimmerly, D. S. (2020) · Clinical Autonomic Research · doi:10.1007/s10286-020-00734-w · Cited by 27 · see citing works
When blood pressure refuses to budge: exploring the complexity of resistant hypertension
Champaneria, M. K., Patel, R., & Oroszi, T. L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1211199 · Cited by 29 · see citing works
An open-source program to analyze spontaneous sympathetic neurohemodynamic transduction
O'Brien, M. W., Petterson, J. L., & Kimmerly, D. S. (2021) · Journal of Neurophysiology · doi:10.1152/jn.00002.2021 · Cited by 26 · see citing works
High Salt Intake Augments Blood Pressure Responses During Submaximal Aerobic Exercise
Babcock, M. C., Robinson, A. T., Migdal, K. U., Watso, J. C., Martens, C. R., Edwards, D. G., Pescatello, L. S., & Farquhar, W. B. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.015633 · Cited by 26 · see citing works
Self-citationde Souza, J. A., Becker, L. K., Batista, M. A. C., et al. (2020) · Experimental Physiology · doi:10.1113/ep088892 · Cited by 21 · see citing works
“Previous studies have reported that diminished sodium intake reduced sympathetic vascular transduction and did not change sympathetic drive in young subjects (Babcock et al., 2019), which indicates that the amount of sodium intake could be affecting sympathetic vascular coupling in healthy subjects.”
BackgroundWatso, J. C., Robinson, A. T., Babcock, M. C., et al. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00149.2019 · Cited by 19 · see citing works
Self-citationKotopoulou, S., Zampelas, A., & Magriplis, E. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.03.015 · Cited by 21 · see citing works
O'Brien, M. W., Ramsay, D. J., O’Neill, C. D., Petterson, J. L., Dogra, S., Mekary, S., & Kimmerly, D. S. (2021) · GeroScience · doi:10.1007/s11357-021-00389-z · Cited by 15 · see citing works
Differential influences of dietary sodium on blood pressure regulation based on race and sex
Robinson, A. T., Wenner, M. M., & Charkoudian, N. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102873 · Cited by 15 · see citing works
Self-citationSalt Loading Blunts Central and Peripheral Postexercise Hypotension
Babcock, M. C., Robinson, A. T., Watso, J. C., Migdal, K. U., Martens, C. R., Edwards, D. G., Pescatello, L. S., & Farquhar, W. B. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002187 · Cited by 15 · see citing works
Self-citationTharpe, M. A., Linder, B. A., Babcock, M. C., Watso, J. C., Pollin, K. U., Hutchison, Z. J., Barnett, A. M., Culver, M. N., Kavazis, A. N., Brian, M. S., et al. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00151.2023 · Cited by 15 · see citing works
Self-citationOverwyk, K. J., Quader, Z. S., Maalouf, J., Bates, M., Webster, J. L., George, M. G., Merritt, R. K., & Cogswell, M. E. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa049 · Cited by 14 · see citing works
Assessing static and dynamic sympathetic transduction using microneurography
Tymko, M. M., Berthelsen, L. F., Skow, R. J., et al. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00032.2021 · Cited by 13 · see citing works
Kou, C., Zhao, X., Fan, X., Lin, X., Wang, Q., & Yu, J. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14667 · Cited by 11 · see citing works
“Cognition was assessed using a questionnaire that included (1) word learning and recall modules from the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD),24 (2) the Animal Fluency test (AFT),25 and (3) the Digit Symbol Substitution Test (DSST)26 in NHANES.”
MethodBiţă, A., Scorei, I. R., Soriano-Ursua, M. A., Mogoşanu, G. D., Belu, I., Ciocîlteu, M. V., Biță, C. E., Rău, G., Pisoschi, C. G., Racu, M.-V., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18060766 · Cited by 14 · see citing works
“The standard DASH diet allows up to 2300 mg of salt per day, whereas a lower Na version reduces Na intake to 1000 mg daily [77,78].”
Tripathi, R., Sullivan, R. D., Fan, T. M., Mehta, R. M., Gladysheva, I. P., & Reed, G. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084035 · Cited by 12 · see citing works
“, human equivalent dose (HED) and is comparable to the average American sodium consumption of about 3400 mg/day and less than the average male diet of 4200 mg/day [8,35].”
BackgroundTakeda, R., Stickford, A. S. L., Best, S. A., Yoo, J., & Fu, Q. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00197.2020 · Cited by 11 · see citing works
Smyth, A., Judge, C. S., Kerins, C., McDermott, S., Niland, A., Corcoran, C., Dineen, R., Alvarez‐Iglesias, A., Nolan, A. M., Mente, A., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101856 · Cited by 10 · see citing works
Teixeira, A. L. D. S., Nardone, M., Fernandes, I. A., et al. (2024) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00009.2024 · Cited by 10 · see citing works
Dietary sodium and health: How much is too much for those with orthostatic disorders?
Stock, J. M., Chelimsky, G. G., Edwards, D. G., & Farquhar, W. B. (2022) · Autonomic Neuroscience · doi:10.1016/j.autneu.2022.102947 · Cited by 9 · see citing works
Self-citationHuang, L., Neal, B. C., Wu, J. H. Y., Huang, Y., Marklund, M., Campbell, N. R. C., He, F. J., Yoshimura, S., Chalmers, J. P., & Trieu, K. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-021-00510-x · Cited by 8 · see citing works
Serum sodium level is inversely associated with new‐onset diabetes in hypertensive patients
Cheng, Q., Liu, X., Cai, A., Zhou, D., Huang, Y., & Feng, Y. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13338 · Cited by 8 · see citing works
Linder, B. A., Babcock, M. C., Pollin, K. U., Watso, J. C., & Robinson, A. T. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00240.2022 · Cited by 8 · see citing works
Self-citationReduced AT 2 R Signaling Contributes to Endothelial Dysfunction After Preeclampsia
Schwartz, K., Sun, M., Jalal, D. I., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.24098 · Cited by 7 · see citing works
“34”
Watso, J. C., Babcock, M. C., Migdal, K. U., Farquhar, W. B., & Robinson, A. T. (2021) · Clinical Autonomic Research · doi:10.1007/s10286-021-00770-0 · Cited by 7 · see citing works
“As described previously [1, 9], we assessed muscle sympathetic nerve activity (MSNA; microneurography), beat-to-beat BP (photoplethysmography), heart rate (electrocardiography), and common femoral artery blood flow (duplex sonography) during 10 min of quiet rest in the supine position in a dimly lit, temperature-contr…”
BackgroundMethodInfluentialSelf-citationJuraschek, S. P., Millar, C. L., Foley, A., Shtivelman, M., Cohen, A., McNally, V., Crevatis, R., Post, S., Mukamal, K. J., Lipsitz, L. A., et al. (2021) · Nutrients · doi:10.3390/nu13030964 · Cited by 6 · see citing works
“The effects of sodium on autonomic function are well-established [24], but may differ in older adults with variable salt sensitivities [25].”
BackgroundTakeda, R., Stickford, A. S. L., Best, S. A., Yoo, J., Liu, Y.-L., & Fu, Q. (2021) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00297.2020 · Cited by 5 · see citing works
Iwelomene, O., Gougeon, A., Burnier, M., Belot, L., Sourd, V., Fauvel, J., & Granal, M. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf340 · Cited by 2 · see citing works
Li, Y., Feng, Q., Wang, S., Li, B., Zheng, B., Peng, N., Li, B., Jiang, Y., Liu, D., Yang, Z., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.07.046 · Cited by 2 · see citing works
Ten days of high dietary sodium does not impair cerebral blood flow regulation in healthy adults
Migdal, K. U., Robinson, A. T., Watso, J. C., Babcock, M. C., Lennon, S. L., Martens, C. R., Serrador, J. M., & Farquhar, W. B. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102826 · Cited by 2 · see citing works
Self-citationNasci, V. L., Benjamin, J. I., Fetter, R. C., Stock, J. M., Romberger, N. T., Watso, J. C., Babcock, M. C., Wenner, M. M., Robinson, A. T., & Gohar, E. Y. (2025) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00119.2025 · Cited by 1 · see citing works
Self-citationA new lead: Sacubitril-valsartan's unique benefit in HFrEF could lie with sympathoinhibition
Nathaniel, S., McGinty, S. J., Witman, M. A., Edwards, D. G., Farquhar, W. B., Hosmane, V. R., & Wenner, M. M. (2022) · Autonomic Neuroscience · doi:10.1016/j.autneu.2022.102949 · Cited by 1 · see citing works
Self-citationWatso, J. C. (2024) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/9f2f-3764
Self-citationWakeham, D. J. (2020) · Cardiff Metropolitan Research Repository (Cardiff Metropolitan University) · doi:10.25401/cardiffmet.13516751
- Authors
- Babcock, M. C., Robinson, A. T., Migdal, K. U., Watso, J. C., Wenner, M. M., Stocker, S. D., & Farquhar, W. B.
- Affiliations
- University of Delaware (US)
- University of Pittsburgh (US)
- ORCID
- Venue
- Hypertension
- Published
- 2019-03
- Volume
- 73
- Issue
- 3
- Pages
- 587-593
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- PMC
- PMC6374182
- OpenAlex
- W2911018560
- Cited by
- 40
- References
- 43
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 7 · 2022: 4 · 2021: 12 · 2020: 7 · 2019: 3
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Heart Association (18POST34060020)
- University of Delaware
- National Institutes of Health (NIH P20 GM113125)
- National Heart, Lung, and Blood Institute (R01HL128388)
- National Institute of General Medical Sciences (P20GM113125)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- dietary sodium reduction, muscle sympathetic nerve activity, renin-angiotensin-aldosterone system, angiotensin II, aldosterone, norepinephrine, blood pressure, cardiovascular mortality
- MeSH terms
- Adult, Blood Pressure, Diet, Sodium-Restricted, Dose-Response Relationship, Drug, Female, Humans, Hypertension, Male, Muscle, Smooth, Vascular, Sympathetic Nervous System, Vascular Resistance, Sodium Chloride, Dietary, Cross-Over Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review